Scrapie infectivity is independent of amyloid staining properties of the N-Terminally truncated prion protein

Journal of Structural Biology

Volumn 130, Issue 2-3, 2000, Pages 323-338

  Wille, Holger ^a,b   Prusiner, Stanley B ^a,b   Cohen, Fred E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Congo red dye binding; Electron microscopy; HFIP; Protein aggregation; Protein conformation; PrP 27 30; Solubilization

Indexed keywords

AMYLOID; PRION PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; HAMSTER; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN CONFORMATION; SCRAPIE; SOLUBILIZATION;

EID: 0033850051     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.2000.4242     Document Type: Article

References (97)

1. Nuclease-resistant polyadenylated RNAs of significant size are detected by PCR in highly purified Creutzfeldt-Jakob disease preparations
2. The exceptionally small size of the scrapie agent
3. Self-assembly of recombinant prion protein of 106 residues
4. Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da
5. Helix promotion in polypeptides by polyols
6. Non-genetic propagation of strain-specific properties of scrapie prion protein
7. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy
8. Examination of the secondary structure of proteins by deconvolved FTIR spectra
9. Prion protein and the transmissible spongiform encephalopathies
10. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state
11. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies
12. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy
13. Effect of polyols and sugars on heat-induced flavin dissociation in glucose oxidase
14. Electron microscopy of amyloid
15. Pathologic conformations of prion proteins
16. Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis
17. Transmissable spongiform encephalopathy (TSE) agents as crystalline forms of the prion protein (PrP) that multiply by allowing normal metabolic forms of PrP to join the crystal
18. Specific volumes of biological macromolecules and some other molecules of biological interest
19. Prionics or the kinetic basis of prion diseases
20. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein
21. Neurotoxicity of a prion protein fragment
22. Amyloid in Alzheimer's disease and prion-related encephalopathies: Studies with synthetic peptides
23. Purified prion proteins and scrapie infectivity copartition into liposomes
24. Properties of scrapie prion proteins in liposomes and amyloid rods
25. Transmissible and non-transmissible amyloidoses: Autocatalytic post-translational conversion of host precursor proteins to β-pleated sheet configurations
26. Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses
27. The transmissible dementias and other brain disorders caused by unconventional viruses-Relationship of transmissible to nontransmissible amyloidosis of the brain
28. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity
29. Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid
30. The relation of the properties of Congo red-stained arayloid fibrils to the beta-conformation
31. +], a heritable prion-like factor of S. cerevisiae
32. Liquid-liquid extraction of low molecular-weight proteins by selective solubilization in reversed micelles
33. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
34. The prion folding problem
35. Protease-resistant prion protein produced in vitro lacks detectable infectivity
36. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein
37. Scrapie: A modified membrane hypothesis
38. Attempts to release the scrapie agent from tissue debris
39. X-ray diffraction analysis of scrapie prion: Intermediate and folded structures in a peptide containing two putative α-helices
40. Halogenated alcohols as solvents for proteins: FTIR spectroscopic studies
41. Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
42. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity
43. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform
44. Molecular properties of complexes formed between the prion protein and synthetic peptides
45. An experimental examination of the scrapie agent in cell membrane mixtures III. Studies of the operational size
46. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly
47. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments
48. Two simple methods for quantifying low-affinity dye-substrate binding
49. Cell-free formation of protease-resistant priori protein
50. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier
51. The stabilization of proteins by sucrose
52. Membrane-free scrapie activity
53. Evidence for the low molecular weight nature of the scrapie agent
54. Clearance of macromolecular and particulate substances from the cerebrospinal fluid system of the rat
55. Infectivity and host responses in Creutzfeldt-Jakob disease
56. Purification of the scrapie agent by density gradient centrifugation
57. A protease-resistant protein is a structural component of the scrapie prion
58. Scrapie prion ultrastructure
59. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis
60. Ultra-structural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells
61. The physico-chemical nature of the scrapie agent
62. Early distribution of radioactive liposomes and scrapie infectivity in mouse tissues following administration by different routes
63. Recombinant scrapie-like prion protein of 106 amino acids is soluble
64. X-ray diffraction of scrapie priori rods and PrP peptides
65. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins
66. In vitro propagation of the prion-like state of yeast Sup35 protein
67. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion
68. Prions
69. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent
70. Partial purification and evidence for multiple molecular forms of the scrapie agent
71. Scrapie prions aggregate to form amyloid-like birefringent rods
72. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication
73. Prion protein biology
74. Disruption of prion rods generates 10-nm spherical particles having high α-helical content and lacking scrapie infectivity
75. The folding intermediate concept of prion protein formation and conformational links to infectivity
76. Differences in the membrane interaction of scrapie amyloid precursor proteins in normal and scrapie- or Creutzfeldt-Jakob disease-infected brains
77. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein
78. Thermal-stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity
79. Eight prion strains have PrP(Sc) molecules with different conformations
80. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein
81. Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins
82. Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation
83. Physical properties of the Creutzfeldt-Jakob disease agent
84. Glycosylinositol phospholipid anchors of the scrapie and cellular priori proteins contain sialic acid
85. Measurements of sedimentation coefficients
86. Ratezonal centrifugation: Quantitative aspects
87. From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation
88. Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice
89. Prion domain initiation of amyloid formation in vitro from native Ure2p
90. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice
91. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity
92. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2
93. Prion protein amyloid: Separation of scrapie infectivity from PrP polymers
94. Ultrastructural studies on scrapie prion protein crystals obtained from reverse micellar solutions
95. Separation of scrapie prion infectivity from PrP amyloid polymers
96. Protein transfer from an aqueous phase into reversed micelles. The effect of protein size and charge distribution
97. Effect of low molecular weight aliphatic alcohols and related compounds on platelet factor 4 subunit association